CARMEL, Ind., Feb. 9 /PRNewswire/ -- The American Psychiatric Association (APA) has chosen CME Enterprise as the sole medical education partner to prepare and manage all industry-supported symposia (ISS) programming at its annual meeting in New Orleans, Louisiana, from May 22-26, 2010. [more]
Rennes, France — February 9th, 2010 -- Biotrial is pleased to announce that it will be exhibiting at the 20th AGAH (Association for Applied Human Pharmacology) Annual Meeting in Hamburg, Germany and at the 9th Annual Phase I Clinical Trials in London, UK. [more]
(BUSINESS WIRE)--Feb 8, 2010 - Amendola Communications Jodi Amendola, CEO of Amendola Communications, is an award-winning public relations and marketing communications expert with two decades of experience in implementing and overseeing strategic marketing and public relations programs for healthcare information technology (HIT) companies. [more]
NEW YORK--(BUSINESS WIRE)--Feb 8, 2010 - ZIOPHARM Oncology, Inc. (Nasdaq: ZIOP) announced today that Jonathan Lewis, MD, PhD, Chief Executive Officer, has been invited to present at the Inaugural UCL One Day Finance Conference to be held on February 15th. The event will take place in London, England at the BMA (British Medical Association) House, once home to Charles Dickens. The conference aims to give participants a unique opportunity to understand finance and learn directly from the people who have been successful, who have navigated turmoil and who have been recognized as leaders within industry. [more]
Opal Events is proud to present our next conference Medical Devices Summit 2010 which will highlight hot button issues in the medical devices industry. There will be a strong focus on key regulations and strategies in compliance to help avoid costly design and production mistakes. [more]
RESEARCH TRIANGLE PARK, N.C. – The North Carolina Biomedical Innovation Network will officially launch with a symposium on February 26, 2010. The symposium will focus on available local facilities that offer high-quality preclinical services and on cutting-edge approaches to accelerate the development of innovative drugs and devices. Speakers for the symposium include: [more]
VILLA GUARDIA, Italy, Feb. 5 /PRNewswire-FirstCall/ -- Gentium S.p.A. (NASDAQ:GENT) today announced that the abstract titled, "Defibrotide prevents hepatic VOD and reduces significantly VOD-associated complications in children at high risk: final results of a prospective phase II/III multicentre study," has been awarded the Van Bekkum Award for the best abstract submitted to the physician's program for the European Group for Blood and Marrow Transplantation's (EBMT) 36th Annual Meeting, to be held in Vienna, March 21-24, 2010. [more]
(BUSINESS WIRE)--Feb 4, 2010 - BioNJ The feature film “Extraordinary Measures” is inspired by the true story of Amicus President and CEO John Crowley, who bucked conventional wisdom and risked his family's fortune to pursue a cure for his children's life-threatening disease. [more]
PHILADELPHIA--(BUSINESS WIRE)--Feb 4, 2010 - Organized by Pharma IQ, a division of IQPC, the 4th Improving Solubility conference will be held March 29-31, 2010 at The Park Hyatt in Philadelphia, PA. [more]
MADISON, Wis.--(BUSINESS WIRE)--Feb 4, 2010 - To be held April 22-23, 2010, the 9th Annual International Bioethics Forum asks, what is consciousness? [more]
SAN ANTONIO, Feb. 4 /PRNewswire/ -- Data from three important studies on tapentadol extended release (ER) tablets, an investigational oral analgesic for the management of moderate to severe chronic pain in patients 18 years of age or older, will be discussed during the poster sessions of the 26th Annual Meeting of the American Academy of Pain Medicine (AAPM), February 3-6, 2010 in San Antonio, TX. [more]
WINSTON-SALEM, N.C., Feb. 3 /PRNewswire-USNewswire/ -- The Regenerative Medicine Foundation today announced the first annual Translational Regenerative Medicine Forum to be held April 6-8, 2010 at the Benton Convention Center in Winston-Salem. [more]
CUMBERLAND, R.I.--(BUSINESS WIRE)--Feb 3, 2010 - Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, today announced the presentation of a scientific poster summarizing the results of in vitro and pharmacokinetic studies for its tamper-resistant, extended-release oral oxycodone formulation (COL-003), which is the lead product candidate utilizing the Company's DETERx™ technology. The poster, entitled, “Tamper-Resistant Properties and Bioavailability of a Novel, Multiparticulate, Extended-Release Formulation of Oxycodone for the Treatment of Moderate to Severe Pain”, will be presented at the American Academy of Pain Medicine's 26th Annual Meeting, February 3-6, in San Antonio, Texas. [more]
ZURICH & BARCELONA, Spain--(BUSINESS WIRE)--Feb 3, 2010 - Leaders from the global biotechnology industry will gather for the 4th annual BIO-Europe Spring® partnering conference in Barcelona, Spain, March 8–10 at the CCIB's Convention Centre. The event will attract more than 1,500 executives from 1,000 companies representing over 40 countries who will engage in upwards of 7,500 one-to-one partnering meetings. [more]
TORONTO--(BUSINESS WIRE)--Feb 3, 2010 - Pharma IQ, a division of IQPC, announces that Kevin O'Donnell Director & CTA of Tegrant Corporation and Chair of IATA's Time & Temperature Task Force will discuss compliance with IATA's revised Chapter 17 at the 8th Cold Chain Management and Temperature Control Summit. [more]
Jodi Amendola, CEO of Amendola Communications, is an award-winning public relations and marketing communications expert with two decades of experience in implementing and overseeing strategic marketing and public relations programs for healthcare information technology (HIT) companies. For the past three consecutive years, Amendola Communications has been honored as one of the information technology (IT) industry's five "Best-of-the-Best" small PR agencies by PRSourceCode's "Top Tech Communicators" study. Additionally, Jodi has been recognized year after year as a “Top PR Pro” for her personal contributions to the media. In 2009, Jodi was named an elite Forty-Under-40 business leader by the Phoenix Business Journal. Jodi also serves on the Board of X2 Health Network (X2HN), a not-for-profit, by-invitation-only executive women's health network.
[more]
WALTHAM, Mass.--(BUSINESS WIRE)--Feb 3, 2010 - Phase Forward, a leading provider of data management solutions for clinical trials and drug safety, will participate in two industry events this month: The 13th Annual DIA Workshop in Japan for Clinical Data Management (Booths 4 and 5) and VIB Pharma's 11th Annual Clinical Trial Supply (Booth 3). [more]
CLEVELAND, Feb. 2 /PRNewswire-FirstCall/ -- DATATRAK International, Inc. (OTCQX: DATA), a technology and services company focused on global eClinical solutions for the clinical trials industry, today announced its attendance at the 13th Annual DIA Workshop in Japan for Clinical Data Management. Laurence Birch, Chairman of the Board, and Bill Coates, Vice President of Sales, will participate in the workshop with DATATRAK's strategic partner, NTT DATA Corporation. The event takes place on February 4th and 5th in Tokyo, Japan. [more]
BOSTON--(BUSINESS WIRE)--Feb 1, 2010 - Humedica, a next-generation clinical informatics company, today announced that it will be presenting at Harvard Business School's 7th Annual Healthcare Conference: “Policy Reform: An Inflection Point for Healthcare Management?” on Saturday, January 30, 2010. [more]
NEW YORK--(BUSINESS WIRE)--Feb 1, 2010 - Medidata Solutions, a leading global provider of hosted clinical development solutions, today announced that members of its management team will deliver the following presentations at key industry events in February: [more]
Mergers & Acquisitions, Partnerships, & Collaborations 2010 – Review and Outlook
This PharmaLive Special Report analyzes the healthcare industry’s M&As of 2009, providing a comprehensive listing of companies’ M&A activity and detailing the top 20 deals within each of the Pharmaceutical, Biotechnology, Specialty, and Medical Device sectors, and previews potential M&A activity within the healthcare arena for 2010.
The introductory rate of $395 expires February 17, 2010.
